Charles River Laboratories | CRL - 市值



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 11.66B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


市值 更改 日
Agilent USD 32.66B 5.2B 2026-03
Align Technology USD 12.28B 1.07B 2026-03
Bruker USD 5.5B 1.66B 2026-03
Cardinal Health USD 49.72B 894M 2026-03
Charles River Laboratories USD 7.85B 2.17B 2026-03
Cigna USD 70.33B 3.19B 2026-03
Concord Medical Services Hldg CNY 166.72M 11.49M 2026-04
CVS Health USD 92.04B 8.7B 2026-03
Danaher USD 128.29B 10.57B 2026-07
Dentsply International USD 2.32B 36M 2026-03
Elevance Health USD 90.53B 6.54B 2026-07
Humana USD 20.82B 9.99B 2026-03
Illumina USD 17.88B 2.74B 2026-03
Incyte USD 18.73B 660M 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Laboratory Of America USD 21.93B 1.13B 2026-03
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
McKesson USD 106B 4.75B 2026-03
Merck EUR 46.78B 6.52B 2026-03
Mettler Toledo International USD 25.54B 2.94B 2026-03
Novartis USD 257.14B 50.62B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Quest Diagnostics USD 25.44B 1.98B 2026-07
Revvity USD 9.94B 1.03B 2026-03
Thermo Fisher Scientific USD 218.23B 27.58B 2026-07
United Therapeutics USD 25.19B 4.21B 2026-03
UnitedHealth USD 390.13B 12.67B 2026-07
Veradigm USD 525M 621M 2026-03
Waters USD 29.87B 7.25B 2026-03
West Pharmaceutical Services USD 26.02B 660M 2026-07